Suzhou Yacoo Science Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Suzhou Yacoo Science Co., Ltd. - overview
Established
2003
Location
Suzhou, Jiangsu, China
Primary Industry
Biotechnology
About
Established in 2003 and based in Suzhou, China, Suzhou Yacoo Science Co. , Ltd is a enterprise specializing in the research, production, distribution and service of IVD Reagents Raw Materials, New Electronic and Chemical Materials, Biobuffers and Pharmaceutical Intermediates. The company has partnerships with Thermo Fisher, Beckman Coulter, Sysmex, Alfa, and TCI. The company has passed ISO 9001 quality system certification, ISO 14001 environmental management system certification, ISO 45001 occupational health and safety management system certification and TFS certification.
The company’s main business is the custom research and production of medical and chemical materials. The company’s self-developed products include "in vitro diagnostic reagents raw materials," "electrochemical new materials," "bio buffers," and "pharmaceutical intermediates. " Its products are used in the fields of medical diagnostics, material science, and pharmaceutical development. Suzhou Yacoo Science Co.
, Ltd. generates revenue by providing a comprehensive range of services, from custom research and development to bulk production of high-quality biopharmaceutical products.
Current Investors
Addor Capital
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Commodity Chemicals
Website
www.yacoo.com.cn
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.